2019 2025 Cultivation Epilepsy 
Cannabis Law Report
JANUARY 12, 2020
It has approved use of cannabis extracts for treatment of a range of illnesses and conditions, including cancer, epilepsy, Alzheimer’s, Parkinson’s disease and anxiety. According to a 2019 study by Grand View Research, a US-based market research firm, the global legal marijuana market is expected to be worth US$66.3
Cannabis Law Report
JUNE 8, 2021
Currently, the development of effective drugs based on CBD for the treatment of Alzheimer’s disease, dementia, diabetes, and epilepsy is underway. By 2025, the capitalization of the industry is expected to grow to $ 200 billion. Almost 3,000 employees, operating income in 2019 – $297 billion. In 2018, the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JULY 26, 2019
The medicinal cannabis is believed to possess traits that cure critical ailments like Cancer, AIDS, cancer, PTSD, depression, epilepsy and seizures. The Australian cannabis market is expected to have a net worth of approximately $55 million by the end of 2025. per cent at A$0.625 on ASX on 25 July 2019.
Cannabis Law Report
JULY 15, 2022
The first Australian company to be licensed to cultivate and manufacture medicinal marijuana has praised the Federal Government’s plan to allow exports of cannabis-based medicines. “We cultivate, we produce, we manufacture, we bottle and then we distribute onsite, which I think for accountability is very important.
Cannabis Law Report
OCTOBER 17, 2019
As more countries legalize or decriminalize the cultivation, manufacture, sale, and use of cannabis, companies across a variety of industries are looking for opportunities to capitalize on this emerging market. CBD candles and outdoor grow lights for home cultivation) are expected to embrace cannabis to various degrees.
Expert insights. Personalized for you.
59 
Let's personalize your content